In this week's advocacy front, NCPA submits call letter comments to CMS, the FDA approves its first biosimilar, and more!

APCI Member and U.S. Representative Buddy Carter (R-Ga.) will be attending the APCI Convention on Sunday, March 1.

Legislative Affairs Director Bill Eley has been busy creating summaries of federal legislation important to community pharmacy. These one-page descriptions of proposed legislation in Congress quickly and easily explain what is in each of the bills, and why they are important.

Information in this week's Advocacy Center Update includes the introduction of a Medicare Part D Any Willing Pharmacy bill, CMS actions agains Aetna, and the release of draft compounding documents.

Three bills have been introduced in Washington that are very important to independent pharmacy and APCI needs your help to encourage your members of Congress and U.S. Senators to support and sign-on as co-sponsors.  The following bills need to have the entire delegations from APCI member states on as co-sponsors: